Corcept Therapeutics | CORT - EPS Earnings Per Share


Corcept Therapeutics reported $1.01 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 1.01 0.23 0.16 Nov/03
FY2026Q2 Jun/2026 0.36 0.01 0.29 Jul/29
FY2026Q1 Mar/2026 -0.30 -0.11 0.17 Apr/30
FY2025Q4 Dec/2025 0.20 0.38 0.26 Feb/24
FY2025Q3 Sep/2025 0.16 0.17 0.41 Nov/04




Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
ANI Pharmaceuticals USD 2.7 0.49 Sep/2026
Ardelyx USD -0.07 0.08 Jun/2026
Aurora Cannabis CAD -0.07 0.06 Jun/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Canopy Growth CAD -0.03 0.37 Jun/2026
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Merck USD 2.49 2.62 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.7 0.03 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
TG Therapeutics USD 0.35 0.3 Sep/2026